Iovance Biotherapeutics Inc (NASDAQ:IOVA) traded at $13290000.0 at last check on current trade day and made an upward move of 2260509% on its previous day’s price.
Looking at the stock we see that its previous close was $1.98 and the beta (5Y monthly) reads 0.863 with the day’s price range being $1.88 – $1.965. In terms of its 52-week price range, IOVA has a high of $12.51 and a low of $1.64. The company’s stock has gained about 7.69% over that past 30 days.
Iovance Biotherapeutics Inc has a market cap of $631.14 million and is expected to release its quarterly earnings report on 2025-May-08.
Based on estimates by 8 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the Iovance Biotherapeutics Inc (IOVA) stock as a Hold, while 6 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -4.28% off its SMA20 and -23.36% from its 50-day simple moving average. The RSI (14) is pointing at 40.75 while the volatility over the past week is 3.43% and jumps to 4.97% over the past one month. The average price target for the stock over the next 12 months is $4, with the estimates having a low of $2 and a high of $6. These price ends are 100.0% and 100.0% off the today’s price level respectively, although investors could be excited at the prospect of a 100.0% if the IOVA share price touches on the median price of $4.
Coming back to Iovance Biotherapeutics Inc (NASDAQ:IOVA), we note that the average 3-month trading volume was 13.29 million, while that of the preceding 10-day period stands at 13.95 million. Current shares outstanding are 333.93 million.
The insiders hold 18.70% of the company’s shares while institutions hold 64.00%. The data shows that short shares as of 2025-05-30, stood at 86.36 million at a short ratio of 4.61. This represents a 2832.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 74.57 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -76.38% down in year-to-date price movement.
